<SEC-DOCUMENT>0001315863-24-000510.txt : 20240614
<SEC-HEADER>0001315863-24-000510.hdr.sgml : 20240614
<ACCEPTANCE-DATETIME>20240614160110
ACCESSION NUMBER:		0001315863-24-000510
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20240614
DATE AS OF CHANGE:		20240614
GROUP MEMBERS:		PABLO LEGORRETA

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PROKIDNEY CORP.
		CENTRAL INDEX KEY:			0001850270
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				981586514
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-92651
		FILM NUMBER:		241044595

	BUSINESS ADDRESS:	
		STREET 1:		2000 FRONTIS PLAZA BLVD.
		STREET 2:		SUITE 250
		CITY:			WINSTON-SALEM
		STATE:			NC
		ZIP:			27103
		BUSINESS PHONE:		336-999-7028

	MAIL ADDRESS:	
		STREET 1:		2000 FRONTIS PLAZA BLVD.
		STREET 2:		SUITE 250
		CITY:			WINSTON-SALEM
		STATE:			NC
		ZIP:			27103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Social Capital Suvretta Holdings Corp. III
		DATE OF NAME CHANGE:	20210310

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tolerantia, LLC
		CENTRAL INDEX KEY:			0001937011
		ORGANIZATION NAME:           	
		IRS NUMBER:				824989989
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		110 EAST 59TH STREET
		STREET 2:		SUITE 3300
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		212-883-8033

	MAIL ADDRESS:	
		STREET 1:		110 EAST 59TH STREET
		STREET 2:		SUITE 3300
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>sc_13da_tolerantia.htm
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Akin Gump Strauss Hauer & Feld
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div><br>
    </div>
    <br>
    <div><br>
    </div>
    <div style="text-align: center; margin-top: 12pt; font-size: 14pt; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; margin-bottom: 6pt; font-weight: bold;">WASHINGTON, D.C. 20549</div>
    <div style="text-align: center; margin-bottom: 2pt;">__________________________________________</div>
    <div style="text-align: center; margin-top: 18pt; font-size: 14pt; font-weight: bold;">SCHEDULE 13D</div>
    <div style="text-align: center; font-weight: bold;">(Rule 13d-101)</div>
    <div style="text-align: center; margin-top: 12pt; font-weight: bold;">UNDER THE SECURITIES EXCHANGE ACT OF 1934</div>
    <div style="text-align: center; margin-bottom: 3pt; font-weight: bold;">(Amendment No. 3)*</div>
    <div style="text-align: center; margin-bottom: 2pt;">__________________________________________</div>
    <div style="text-align: center; margin-top: 12pt; font-size: 14pt; font-weight: bold;">ProKidney Corp.</div>
    <div style="text-align: center; font-weight: bold;">(Name of Issuer)</div>
    <div style="text-align: center; margin-top: 12pt; font-weight: bold;">Class A ordinary shares, par value $0.0001 per share</div>
    <div style="text-align: center; font-weight: bold;">(Title of Class of Securities)</div>
    <div style="text-align: center; margin-top: 12pt; font-weight: bold;">G7S53R104</div>
    <div style="text-align: center; font-weight: bold;">(CUSIP Number)</div>
    <div style="text-align: center; margin-top: 12pt; font-weight: bold;">Tolerantia, LLC</div>
    <div style="text-align: center; font-weight: bold;">110 East 59th Street</div>
    <div style="text-align: center; font-weight: bold;">Suite 2800</div>
    <div style="text-align: center; font-weight: bold;">New York, New York 10022</div>
    <div style="text-align: center; font-weight: bold;">(212) 883-0200</div>
    <div style="text-align: center; font-weight: bold;">(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)</div>
    <div style="text-align: center; margin-top: 6pt; font-style: italic; font-weight: bold;">With copies to:</div>
    <div style="text-align: center; margin-top: 6pt; font-weight: bold;">Jason Daniel</div>
    <div style="text-align: center; font-weight: bold;">Akin Gump Strauss Hauer &amp; Feld LLP</div>
    <div style="text-align: center; font-weight: bold;">2300 N. Field Street</div>
    <div style="text-align: center; font-weight: bold;">Suite 1800</div>
    <div style="text-align: center; font-weight: bold;">Dallas, TX 75201</div>
    <div style="text-align: center; font-weight: bold;">(214) 969-4209</div>
    <div style="text-align: center; margin-top: 12pt; font-weight: bold;">June 13, 2024</div>
    <div style="text-align: center; font-weight: bold;">(Date of Event which Requires Filing of this Statement)</div>
    <div style="margin-top: 6pt;">If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and
      is filing this schedule because of &#167;&#167; 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div style="margin-top: 3pt; margin-bottom: 3pt;">Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all
      exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.</div>
    <table cellspacing="0" cellpadding="0" id="zeee936629e3c44ee9704b4b3506d987f" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div>*</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div>The remainder of this cover page shall be filled out for a reporting person&#8217;s initial filing on this form with respect to the subject class of
              securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.</div>
          </td>
        </tr>

    </table>
    <div style="margin-top: 3pt;">The information required on the remainder of this cover page shall not be deemed to be &#8220;filed&#8221; for the purpose of Section 18 of the
      Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section of the Exchange Act but shall be subject to all other provisions of the Exchange Act (however, see the Notes).</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div>CUSIP No. G7S53R104</div>
    <table cellspacing="0" cellpadding="0" id="z77271e42072b42b985032956d08cf566" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 2.72%; vertical-align: middle;">
            <div style="font-size: 12pt;">&#160;</div>
          </td>
          <td style="width: 0.58%; vertical-align: bottom;">&#160;</td>
          <td style="width: 19.44%; vertical-align: middle;" colspan="5">&#160;</td>
          <td style="width: 19.34%; vertical-align: bottom;" colspan="6">&#160;</td>
          <td style="width: 19.31%; vertical-align: middle;" colspan="2">&#160;</td>
          <td style="width: 19.31%; vertical-align: bottom;" colspan="2">&#160;</td>
          <td style="width: 19.31%; vertical-align: middle;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 2.72%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>1</div>
          </td>
          <td style="width: 0.58%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 96.69%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="17">
            <div>NAMES OF REPORTING PERSONS</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>Tolerantia, LLC</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.72%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>2</div>
          </td>
          <td style="width: 0.58%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 96.69%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="17">
            <div>CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</div>
            <div>(a) &#9744; (b) &#9744;</div>
            <div style="font-size: 12pt;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.72%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>3</div>
          </td>
          <td style="width: 0.58%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 96.69%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="17">
            <div>SEC USE ONLY</div>
            <div style="font-size: 12pt;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.72%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>4</div>
          </td>
          <td style="width: 0.58%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 96.69%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="17">
            <div>SOURCE OF FUNDS (SEE INSTRUCTIONS)</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>AF</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.72%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>5</div>
          </td>
          <td style="width: 0.58%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 96.69%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="17">
            <div>CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.72%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>6</div>
          </td>
          <td style="width: 0.58%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 96.69%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="17">
            <div>CITIZENSHIP OR PLACE OF ORGANIZATION</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>United States</div>
          </td>
        </tr>
        <tr>
          <td style="width: 11.16%; vertical-align: middle;" colspan="5">&#160;</td>
          <td style="width: 11.16%; vertical-align: bottom;">&#160;</td>
          <td style="width: 11.16%; vertical-align: middle;" colspan="3">&#160;</td>
          <td style="width: 1.21%; vertical-align: bottom;">&#160;</td>
          <td style="width: 4.34%; vertical-align: middle;">&#160;</td>
          <td style="width: 1.21%; vertical-align: bottom;">&#160;</td>
          <td style="width: 59.76%; vertical-align: middle;" colspan="7">&#160;</td>
        </tr>
        <tr>
          <td style="width: 33.47%; vertical-align: middle;" rowspan="4" colspan="9">
            <div style="text-align: center;">NUMBER OF</div>
            <div style="text-align: center;">SHARES</div>
            <div style="text-align: center;">BENEFICIALLY</div>
            <div style="text-align: center;">OWNED BY</div>
            <div style="text-align: center;">EACH</div>
            <div style="text-align: center;">REPORTING</div>
            <div style="text-align: center;">PERSON</div>
            <div style="text-align: center;">WITH</div>
            <div>&#160;</div>
          </td>
          <td style="width: 1.21%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 4.34%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>7</div>
          </td>
          <td style="width: 1.21%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 59.76%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="7">
            <div>SOLE VOTING POWER</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.58%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 0.11%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>8</div>
          </td>
          <td style="width: 0.87%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 34.74%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="7">
            <div>SHARED VOTING POWER</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>111,257,870<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.58%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 0.11%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>9</div>
          </td>
          <td style="width: 0.87%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 34.74%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="7">
            <div>SOLE DISPOSITIVE POWER</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.58%; vertical-align: bottom;">
            <div>&#160;</div>
          </td>
          <td style="width: 0.11%; vertical-align: top;">
            <div>10</div>
          </td>
          <td style="width: 0.87%; vertical-align: bottom;">
            <div>&#160;</div>
          </td>
          <td style="width: 34.74%; vertical-align: top;" colspan="7">
            <div>SHARED DISPOSITIVE POWER</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>111,257,870<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.42%; vertical-align: middle;" colspan="3">&#160;</td>
          <td style="width: 0.87%; vertical-align: bottom;">&#160;</td>
          <td style="width: 19.22%; vertical-align: middle;" colspan="4">&#160;</td>
          <td style="width: 19.19%; vertical-align: bottom;" colspan="6">&#160;</td>
          <td style="width: 19.11%; vertical-align: middle;" colspan="2">&#160;</td>
          <td style="width: 19.1%; vertical-align: bottom;" colspan="2">&#160;</td>
          <td style="width: 19.08%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 3.42%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="3">
            <div>11</div>
          </td>
          <td style="width: 0.87%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 95.71%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="15">
            <div>AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>111,257,870<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.42%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="3">
            <div>12</div>
          </td>
          <td style="width: 0.87%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 95.71%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="15">
            <div>CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.42%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="3">
            <div>13</div>
          </td>
          <td style="width: 0.87%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 95.71%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="15">
            <div>PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>38.7%<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.42%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="3">
            <div>14</div>
          </td>
          <td style="width: 0.87%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 95.71%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="15">
            <div>TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>OO</div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.42%; vertical-align: top;" colspan="3">
            <div>(1)</div>
          </td>
          <td style="width: 96.58%; vertical-align: top;" colspan="16">
            <div>Represents 22,617,909 Class A ordinary shares, $0.0001 par value (the &#8220;Class A ordinary shares&#8221;), and 88,639,961 Class B ordinary shares, $0.0001 par
              value (the &#8220;Class B ordinary shares&#8221;), of ProKidney Corp. (&#8220;ProKidney&#8221;), held by or for the benefit of<font style="font-weight: bold;">&#160;</font>Tolerantia, LLC, a Delaware limited
              liability company (&#8220;Tolerantia&#8221;), which is an affiliate controlled and majority-owned by Mr. Pablo Legorreta (together with Tolerantia, the &#8220;Reporting Persons&#8221;). Mr. Legorreta controls the voting and disposition of the shares held by or for
              the benefit of Tolerantia. Mr. Legorreta disclaims beneficial ownership of the shares held by Tolerantia except to the extent of his indirect pecuniary interest therein. The business address of Tolerantia is 110 East 59th Street, Suite 2800,
              New York, New York, 10022. The Reporting Persons have the right to exchange their common units of ProKidney LP (the &#8220;Common Units&#8221;) and an equal number of Class B ordinary shares on a one-for-one basis for Class A ordinary shares.</div>
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.42%; vertical-align: top;" colspan="3">
            <div>(2)</div>
          </td>
          <td style="width: 96.58%; vertical-align: top;" colspan="16">
            <div>ProKidney reported that it has 287,261,909 shares of Class A ordinary
                shares and Class B ordinary shares outstanding on a combined basis as of June 13, 2024 in ProKidney&#8217;s final prospectus on Form 424 filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on June 13, 2024 plus the number of
              shares issued due to the partial exercise of the overallotment option. If the beneficial ownership percentage were computed based solely on the outstanding Class A
                ordinary shares and the Class A ordinary shares issuable upon the conversion of Class B ordinary shares and the exchange of the Common Units, which are deemed to be beneficially owned by Tolerantia, Tolerantia would beneficially own 53.4%.</div>
          </td>
        </tr>

    </table>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div>CUSIP No. G7S53R104</div>
    <table cellspacing="0" cellpadding="0" id="zefe6cac0977a4806b82d0466c13324ff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 2.72%; vertical-align: middle;">&#160;</td>
          <td style="width: 0.58%; vertical-align: bottom;">&#160;</td>
          <td style="width: 19.44%; vertical-align: middle;" colspan="5">&#160;</td>
          <td style="width: 19.34%; vertical-align: bottom;" colspan="6">&#160;</td>
          <td style="width: 19.31%; vertical-align: middle;" colspan="2">&#160;</td>
          <td style="width: 19.31%; vertical-align: bottom;" colspan="2">&#160;</td>
          <td style="width: 19.31%; vertical-align: middle;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 2.72%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>1</div>
          </td>
          <td style="width: 0.58%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 96.69%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="17">
            <div>NAMES OF REPORTING PERSONS</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>Pablo Legorreta</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.72%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>2</div>
          </td>
          <td style="width: 0.58%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 96.69%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="17">
            <div>CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</div>
            <div>(a) &#9744; (b) &#9744;</div>
            <div style="font-size: 12pt;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.72%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>3</div>
          </td>
          <td style="width: 0.58%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 96.69%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="17">
            <div>SEC USE ONLY</div>
            <div style="font-size: 12pt;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.72%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>4</div>
          </td>
          <td style="width: 0.58%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 96.69%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="17">
            <div>SOURCE OF FUNDS (SEE INSTRUCTIONS)</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>BK, PF</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.72%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>5</div>
          </td>
          <td style="width: 0.58%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 96.69%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="17">
            <div>CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.72%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>6</div>
          </td>
          <td style="width: 0.58%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 96.69%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="17">
            <div>CITIZENSHIP OR PLACE OF ORGANIZATION</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>United States</div>
          </td>
        </tr>
        <tr>
          <td style="width: 11.16%; vertical-align: middle;" colspan="5">&#160;</td>
          <td style="width: 11.16%; vertical-align: bottom;">&#160;</td>
          <td style="width: 11.16%; vertical-align: middle;" colspan="3">&#160;</td>
          <td style="width: 1.21%; vertical-align: bottom;">&#160;</td>
          <td style="width: 4.34%; vertical-align: middle;">&#160;</td>
          <td style="width: 1.21%; vertical-align: bottom;">&#160;</td>
          <td style="width: 59.76%; vertical-align: middle;" colspan="7">&#160;</td>
        </tr>
        <tr>
          <td style="width: 33.47%; vertical-align: middle;" rowspan="4" colspan="9">
            <div style="text-align: center;">NUMBER OF</div>
            <div style="text-align: center;">SHARES</div>
            <div style="text-align: center;">BENEFICIALLY</div>
            <div style="text-align: center;">OWNED BY</div>
            <div style="text-align: center;">EACH</div>
            <div style="text-align: center;">REPORTING</div>
            <div style="text-align: center;">PERSON</div>
            <div style="text-align: center;">WITH</div>
            <div>&#160;</div>
          </td>
          <td style="width: 1.21%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 4.34%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>7</div>
          </td>
          <td style="width: 1.21%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 59.76%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="7">
            <div>SOLE VOTING POWER</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.58%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 0.11%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>8</div>
          </td>
          <td style="width: 0.87%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 34.74%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="7">
            <div>SHARED VOTING POWER</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>111,257,870<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.58%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 0.11%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>9</div>
          </td>
          <td style="width: 0.87%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 34.74%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="7">
            <div>SOLE DISPOSITIVE POWER</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.58%; vertical-align: bottom;">
            <div>&#160;</div>
          </td>
          <td style="width: 0.11%; vertical-align: top;">
            <div>10</div>
          </td>
          <td style="width: 0.87%; vertical-align: bottom;">
            <div>&#160;</div>
          </td>
          <td style="width: 34.74%; vertical-align: top;" colspan="7">
            <div>SHARED DISPOSITIVE POWER</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>111,257,870<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.42%; vertical-align: middle;" colspan="3">&#160;</td>
          <td style="width: 0.87%; vertical-align: bottom;">&#160;</td>
          <td style="width: 19.22%; vertical-align: middle;" colspan="4">&#160;</td>
          <td style="width: 19.19%; vertical-align: bottom;" colspan="6">&#160;</td>
          <td style="width: 19.11%; vertical-align: middle;" colspan="2">&#160;</td>
          <td style="width: 19.1%; vertical-align: bottom;" colspan="2">&#160;</td>
          <td style="width: 19.08%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 3.42%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="3">
            <div>11</div>
          </td>
          <td style="width: 0.87%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 95.71%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="15">
            <div>AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>111,257,870<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.42%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="3">
            <div>12</div>
          </td>
          <td style="width: 0.87%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 95.71%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="15">
            <div>CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.42%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="3">
            <div>13</div>
          </td>
          <td style="width: 0.87%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 95.71%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="15">
            <div>PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>38.7%<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.42%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="3">
            <div>14</div>
          </td>
          <td style="width: 0.87%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div>&#160;</div>
          </td>
          <td style="width: 95.71%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="15">
            <div>TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)</div>
            <div style="font-size: 12pt;">&#160;</div>
            <div>IN</div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.42%; vertical-align: top;" colspan="3">
            <div>(1)</div>
          </td>
          <td style="width: 96.58%; vertical-align: top;" colspan="16">
            <div>Represents 22,617,909 Class A ordinary shares and 88,639,961 Class B ordinary shares held by or for the benefit of<font style="font-weight: bold;">&#160;</font>Tolerantia, which is an affiliate controlled and majority-owned by Mr. Pablo Legorreta. Mr. Legorreta controls the voting and disposition of the shares held by or for
              the benefit of<font style="font-weight: bold;">&#160;</font>Tolerantia. Mr. Legorreta disclaims beneficial ownership of the shares held by Tolerantia except to the extent of his
              indirect pecuniary interest therein. The business address of Tolerantia is 110 East 59th Street, Suite 2800, New York, New York, 10022. The Reporting Persons have the right to exchange their Common Units and an equal number of Class B
              ordinary shares on a one-for-one basis for Class A ordinary shares.</div>
            <div> <br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.42%; vertical-align: top;" colspan="3">
            <div>(2)</div>
          </td>
          <td style="width: 96.58%; vertical-align: top;" colspan="16">
            <div>ProKidney reported that it has 287,261,909 shares of Class A ordinary
                shares and Class B ordinary shares outstanding on a combined basis as of June 13, 2024 in ProKidney&#8217;s final prospectus on Form 424 filed with the SEC on June 13, 2024 plus the number of shares issued due to the partial exercise of
              the overallotment option. If Mr. Legorreta&#8217;s beneficial ownership percentage were computed based solely on the outstanding Class A ordinary shares and the Class A
                ordinary shares issuable upon the conversion of Class B ordinary shares and the exchange of the Common Units held by Tolerantia, which are deemed to be beneficially owned by Mr. Legorreta, Mr. Legorreta would beneficially own 53.4%.</div>
          </td>
        </tr>

    </table>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">AMENDMENT NO. 3 TO SCHEDULE 13D</div>
    <div><br>
    </div>
    <div>This Amendment No. 3 to Schedule 13D amends and supplements the Schedule 13D filed by the undersigned with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
      on July 22, 2022, as amended and supplemented on November 2, 2023 and February 6, 2024 (collectively, the &#8220;Schedule 13D&#8221;). All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule
      13D.</div>
    <div style="margin-top: 18pt; font-weight: bold;">Item 3. Source or Amount of Funds or Other Consideration.</div>
    <div><br>
    </div>
    <div>Item 3 of Schedule 13D is supplemented and superseded, as the case may be, as follows:</div>
    <div><br>
    </div>
    <div>An affiliate of Mr. Legorreta borrowed $50,000,000 from an investment-related credit facility with Morgan Stanley Private Bank, National Association to fund a
      portion of the acquisition made by the Reporting Persons described below.&#160; The loan was not secured by the securities described herein. The remaining portion of the acquisition cost was paid with personal funds.</div>
    <div><br>
    </div>
    <div>The information set forth in Item 4 of this Schedule 13D is incorporated herein by reference.</div>
    <div style="margin-top: 18pt; font-weight: bold;">Item 4. Purpose of Transaction.</div>
    <div><br>
    </div>
    <div>Item 4 of Schedule 13D is supplemented and superseded, as the case may be, as follows:</div>
    <div><br>
    </div>
    <div>On June 11, 2024, the Issuer entered into an underwriting agreement with Jefferies LLC, J.P. Morgan Securities LLC, and Guggenheim Securities, LLC as the
      representatives of the underwriters named therein relating to an underwritten public offering (the &#8220;Offering&#8221;) of Class A ordinary shares at a public offering price of $2.42 per share.&#160; The Offering closed on June 13, 2024, and the Reporting Persons
      purchased 22,617,909 Class A ordinary shares in the Offering at a price of $2.42 per share.</div>
    <div style="margin-top: 18pt; font-weight: bold;">Item 5. Interest in Securities of the Issuer.</div>
    <div style="margin-top: 6pt;">(a) &#8211; (b)</div>
    <div style="margin-top: 12pt;">Tolerantia:</div>
    <div style="font-size: 8pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zca45b30c5bfb40e69d267e7683431b58" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 0.46%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 2.07%; vertical-align: top;">
            <div>&#8226;</div>
          </td>
          <td style="width: 1.46%; vertical-align: top;">
            <div>&#160;</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div>Amount beneficially owned: 111,257,870</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.46%; vertical-align: middle;">&#160;</td>
          <td style="width: 2.07%; vertical-align: top;">
            <div>&#8226;</div>
          </td>
          <td style="width: 1.46%; vertical-align: top;">&#160;</td>
          <td style="width: 96%; vertical-align: top;">
            <div>Percent of Class: 38.7% based on the number of Class A ordinary shares
                and Class B ordinary shares outstanding on a combined basis and 53.4% based solely on the outstanding Class A ordinary shares and the Class A ordinary
                shares issuable upon the conversion of Class B ordinary shares and the exchange of the Common Units beneficially owned by or for the benefit of<font style="font-weight: bold;">&#160;</font>Tolerantia as set forth below</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.46%; vertical-align: middle;">&#160;</td>
          <td style="width: 2.07%; vertical-align: top;">
            <div>&#8226;</div>
          </td>
          <td style="width: 1.46%; vertical-align: top;">&#160;</td>
          <td style="width: 96%; vertical-align: top;">
            <div>Number of shares the Reporting Person has:</div>
          </td>
        </tr>

    </table>
    <div style="font-size: 8pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z4fd5ca3b9a514f9dbbc1d52408d71bd4" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 7.48%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 1.66%; vertical-align: top;">
            <div>&#8226;</div>
          </td>
          <td style="width: 1.68%; vertical-align: top;">
            <div>&#160;</div>
          </td>
          <td style="width: 89.18%; vertical-align: top;">
            <div>Sole power to vote or direct the vote: 0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.48%; vertical-align: middle;">&#160;</td>
          <td style="width: 1.66%; vertical-align: top;">
            <div>&#8226;</div>
          </td>
          <td style="width: 1.68%; vertical-align: top;">&#160;</td>
          <td style="width: 89.18%; vertical-align: top;">
            <div>Shared power to vote: 111,257,870</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.48%; vertical-align: middle;">&#160;</td>
          <td style="width: 1.66%; vertical-align: top;">
            <div>&#8226;</div>
          </td>
          <td style="width: 1.68%; vertical-align: top;">&#160;</td>
          <td style="width: 89.18%; vertical-align: top;">
            <div>Sole power to dispose or direct the disposition of: 0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.48%; vertical-align: middle;">&#160;</td>
          <td style="width: 1.66%; vertical-align: top;">
            <div>&#8226;</div>
          </td>
          <td style="width: 1.68%; vertical-align: top;">&#160;</td>
          <td style="width: 89.18%; vertical-align: top;">
            <div>Shared power to dispose or direct the disposition of: 111,257,870</div>
          </td>
        </tr>

    </table>
    <div style="font-size: 8pt;">&#160;</div>
    <div>Pablo Legorreta:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zd1b97c81f2b8405dbf910b0ff602fe87" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 0.46%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 2.07%; vertical-align: top;">
            <div>&#8226;</div>
          </td>
          <td style="width: 1.46%; vertical-align: top;">
            <div>&#160;</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div>Amount beneficially owned: 111,257,870</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.46%; vertical-align: middle;">&#160;</td>
          <td style="width: 2.07%; vertical-align: top;">
            <div>&#8226;</div>
          </td>
          <td style="width: 1.46%; vertical-align: top;">&#160;</td>
          <td style="width: 96%; vertical-align: top;">
            <div>Percent of Class: 38.7% based on the number of Class A ordinary shares
                and Class B ordinary shares outstanding on a combined basis and 53.4% based on the outstanding Class A ordinary shares and the Class A ordinary shares
                issuable upon the conversion of Class B ordinary shares and the exchange of the Common Units held by or for the benefit of Tolerantia, which are deemed to be beneficially owned by Mr. Legorreta as set forth below</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.46%; vertical-align: middle;">&#160;</td>
          <td style="width: 2.07%; vertical-align: top;">
            <div>&#8226;</div>
          </td>
          <td style="width: 1.46%; vertical-align: top;">&#160;</td>
          <td style="width: 96%; vertical-align: top;">
            <div>Number of shares the Reporting Person has:</div>
          </td>
        </tr>

    </table>
    <div style="font-size: 8pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z57b1a3d1f48a4e098dd766ce4c597fb1" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 7.48%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 1.66%; vertical-align: top;">
            <div>&#8226;</div>
          </td>
          <td style="width: 1.68%; vertical-align: top;">
            <div>&#160;</div>
          </td>
          <td style="width: 89.18%; vertical-align: top;">
            <div>Sole power to vote or direct the vote: 0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.48%; vertical-align: middle;">&#160;</td>
          <td style="width: 1.66%; vertical-align: top;">
            <div>&#8226;</div>
          </td>
          <td style="width: 1.68%; vertical-align: top;">&#160;</td>
          <td style="width: 89.18%; vertical-align: top;">
            <div>Shared power to vote: 111,257,870</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.48%; vertical-align: middle;">&#160;</td>
          <td style="width: 1.66%; vertical-align: top;">
            <div>&#8226;</div>
          </td>
          <td style="width: 1.68%; vertical-align: top;">&#160;</td>
          <td style="width: 89.18%; vertical-align: top;">
            <div>Sole power to dispose or direct the disposition of: 0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.48%; vertical-align: middle;">&#160;</td>
          <td style="width: 1.66%; vertical-align: top;">
            <div>&#8226;</div>
          </td>
          <td style="width: 1.68%; vertical-align: top;">&#160;</td>
          <td style="width: 89.18%; vertical-align: top;">
            <div>Shared power to dispose or direct the disposition of: 111,257,870</div>
          </td>
        </tr>

    </table>
    <div style="margin-top: 12pt;">Mr. Legorreta controls the voting and disposition of the shares held by Tolerantia. Mr. Legorreta disclaims beneficial ownership of the
      shares held by Tolerantia except to the extent of his indirect pecuniary interest therein.</div>
    <div style="margin-top: 12pt;">The aggregate percentage of Class A ordinary shares reported as beneficially owned by each Reporting Person is determined in accordance with
      SEC rules and is based upon a total of 287,261,909 shares, comprising 119,538,356 Class A ordinary shares and 167,723,553 Class B ordinary shares outstanding as of June 13, 2024, which is the total number of shares outstanding as reported in ProKidney&#8217;s final prospectus on Form 424 filed with the SEC on June 13, 2024 plus the number of shares issued due to the partial exercise of the overallotment option. The Reporting Persons have the right to exchange their Common Units and an equal number of Class B ordinary shares on a one-for-one basis for Class A ordinary shares. The
      applicable SEC rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to those securities and include Class A ordinary shares issuable upon the conversion or
      exercise of other securities that are immediately convertible or exercisable, or are convertible or exercisable within 60 days of the filing of this Schedule 13D.</div>
    <div style="margin-top: 12pt;">(c) Except as set forth in this Schedule 13D, no Reporting Person has effected any transaction in Issuer Class A ordinary shares in the past
      60 days.</div>
    <div style="margin-top: 12pt;">(d) To the best knowledge of each Reporting Person, no one other than the Reporting Persons identified herein has the right to receive or
      the power to direct the receipt of dividends from, or the proceeds from the sale of, the Class A ordinary shares reported herein as beneficially owned by any Reporting Person.</div>
    <div style="margin-top: 12pt;">(e) Not applicable.</div>
    <div style="margin-top: 18pt; font-weight: bold;">Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.</div>
    <div><br>
    </div>
    <div>Item 6 of Schedule 13D is supplemented and superseded, as the case may be, as follows:</div>
    <div><br>
    </div>
    <div>In connection with ProKidney&#8217;s launch of the underwritten offering described in Item 4, Pablo Legorreta entered into a lock-up agreement with the underwriters
      to prohibit the sale of Class A ordinary shares or Class B ordinary shares for 90 days after the date of the final prospectus.</div>
    <div style="margin-top: 18pt; font-weight: bold;">Item 7. Material to be Filed as Exhibits.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zb8a758994c8f443a98e5d705a2e88ec1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top;">99.1</td>
          <td style="width: auto; vertical-align: top;">
            <div>Form of Lock-Up Agreement, which is incorporated by reference to Exhibit A to the Underwriting Agreement, filed as Exhibit 1.1 to ProKidney&#8217;s Current Report on Form 8-K
              filed with the SEC on June 13, 2024.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">SIGNATURE</div>
    <div style="margin-top: 12pt;">After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
      complete and correct.</div>
    <div style="margin-top: 18pt;">Dated: June 14, 2024</div>
    <div style="font-size: 12pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zde90f67b7a9b45c0a7745681eea23202" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 23.56%; vertical-align: middle;">&#160;</td>
          <td style="width: 4.07%; vertical-align: bottom;">&#160;</td>
          <td style="width: 72.37%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;" colspan="3">
            <div style="font-weight: bold;">TOLERANTIA, LLC</div>
          </td>
        </tr>
        <tr>
          <td style="width: 23.56%; vertical-align: middle;">&#160;</td>
          <td style="width: 76.44%; vertical-align: middle;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 23.56%; vertical-align: top;">
            <div>By:</div>
          </td>
          <td style="width: 4.07%; vertical-align: bottom;">
            <div>&#160;</div>
          </td>
          <td style="width: 72.37%; vertical-align: top; border-bottom: 2px solid #000000;">
            <div>
              <div>/s/ Jaime Gomez-Sotomayor</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 23.56%; vertical-align: top;">&#160;</td>
          <td style="width: 4.07%; vertical-align: bottom;">
            <div>&#160;</div>
          </td>
          <td style="width: 72.37%; vertical-align: top;">
            <div>Name: Jaime Gomez-Sotomayor</div>
            <div>Title: Authorized Signatory</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: middle;" colspan="3">&#160;</td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;" colspan="3">
            <div style="font-weight: bold;">PABLO LEGORRETA</div>
          </td>
        </tr>
        <tr>
          <td style="width: 23.56%; vertical-align: middle;">&#160;</td>
          <td style="width: 76.44%; vertical-align: middle;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 23.56%; vertical-align: top;">
            <div>By:</div>
          </td>
          <td style="width: 4.07%; vertical-align: bottom;">
            <div>&#160;</div>
          </td>
          <td style="width: 72.37%; vertical-align: top; border-bottom: 2px solid #000000;">
            <div>
              <div>/s/ Pablo Legorreta</div>
            </div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
